The FDA granted premarket approval to Recell, a spray-on-skin agent, to treat burns in patients aged older than 18 years, its manufacturer announced.
Recell (Avita) uses a small amount of a patient’s own skin to prepare Spray-On Skin Cells at the point of care in about 30 minutes. The agent can be used by itself to treat partial-thickness burns or in combination with autografting for the treatment of full-thickness burns and can be used to treat a wound up to 80 times the size of the donor skin sample. This is equivalent to a skin sample approximately the size of a credit card being used to treat a wound that covers a patient’s entire back, according to Avita.
No commercial support for this activity.
Search Healio's robust listing of national and international medical meetings.
Tell us what you think about Healio.com »
Get the latest news and education delivered to your inbox
©2018 Healio All Rights Reserved.